CH311613A - Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). - Google Patents
Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).Info
- Publication number
- CH311613A CH311613A CH311613DA CH311613A CH 311613 A CH311613 A CH 311613A CH 311613D A CH311613D A CH 311613DA CH 311613 A CH311613 A CH 311613A
- Authority
- CH
- Switzerland
- Prior art keywords
- methyl
- anilide
- chloro
- amine
- fatty acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure- (2-halogen-6-methyl-anilids).
Gegenstand des vorliegenden Patentes bildet ein Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6 methyl-anilids), welches dadurch gekennzeich- net ist, dass man eine Verbindung der Formel
EMI1.1
in welcher X einen reaktionsfähigen, während der Reaktion sich abspaltenden Rest bedeutet, mit N-Methyl N-cyelohexyl-amin umsetzt.
Der Rest X kann in einem Halogenatom oder einem sonstigen für den Austausch gegen den basischen Rest geeigneten reaktionsfähigen Substituenten, wie z. B. einer Alkylsul- fonyloxy-oder Arylsulfonyloxygruppe, bestehen. Der Austausch der Gruppe X gegen den Methyl-eyelohexyl-aminrest erfolgt z. B. durch einfaches Erwärmen mit Methyl-cyclohexylamin gegebenenfalls in Gegenwart eines basisch reagierenden Ysationsmittels oder von Methyl-cyclohexyl-amin im Überschuss. Das N-Methyl-N-cyclohexyl-amino-acet (2-chlor-6-methyl-anilid) ist ein farbloses 01.
Das Hydroehlorid der Base schmilzt bei 164 bis 166".
Das neue Anilid soll als Lokalanästhetikum und als Zwischenprodukt zur Herstellung weiterer Derivate Verwendung finden.
Beispiel:
36 Gewiehtsteile Chloracet- (2-chlor-6-me- thyl-anilid) (gewonnen durch Umsetzen von 2 Chlor-6-methyl-anilin mit Chloracetylehlorid in Gegenwart von Natriumacetat, Schmp. 140 bis 141 ) werden in 80 Gewichtsteilen Äthanol suspendiert und mit 57 Gewichtsteilen N-Me thyl-N-eyelohexyl-amin versetzt. Die Temperatur steigt dabei leicht an und ein grosser Teil des Reaktionsgemisehes geht in Lösung, Nun wird während 4 Stunden bei Zimmertemperatur gerührt und dann einige Stunden bei 65 bis 75 . Eine Probe mit Wasser und nachfol- gend mit verdünnter Salzsäure versetzt,
ergibt wieder Lösung des ausgefallenen Niederschla- ges. Mit Wasserdampf wird hierauf der Alkohol und das iibersehiissige N-Methyl-N-eyclo- hexyl-amin abgeblasen und nach dem Erkalten das zurüekbleibende 61 in Äther aufgenommen, Nach dem Trocknen der ätherischen Losung und Verjagen des Losungsmittels verbleibt ein öl, das durch Vakuumdestillation gereinigt wird. Man erhält 42 Gewichtsteile reines N-Methyl-N-eyelohexyl-amino-acet- (2- chlor-6-methyl-anilid). Die Umsetzung mit cyclohexylamin kann auch in Benzol stattfinden.
PATE RUCH :
Verfahren zur Hestellung eines neuen basiseh substituierten E'ettsäure-(2-hw methyl-anilids), dadurch gekennzeichnet, dass man eine Verbindung der Formel
**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.
Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
The subject matter of the present patent is a process for the preparation of a new basic substituted fatty acid (2-halogen-6-methyl-anilide), which is characterized in that a compound of the formula
EMI1.1
in which X denotes a reactive radical which is split off during the reaction, reacts with N-methyl N-cyelohexyl-amine.
The radical X can be in a halogen atom or any other reactive substituent suitable for replacement with the basic radical, such as. B. an alkylsulfonyloxy or arylsulfonyloxy group exist. The exchange of group X against the methyl-eyelohexyl-aminerest takes place z. B. by simply heating with methyl-cyclohexylamine, optionally in the presence of a basic Ysationsmittel or methyl-cyclohexyl-amine in excess. The N-methyl-N-cyclohexyl-amino-acet (2-chloro-6-methyl-anilide) is a colorless 01.
The hydrochloride of the base melts at 164 to 166 ".
The new anilide is to be used as a local anesthetic and as an intermediate product for the production of further derivatives.
Example:
36 parts by weight of chloroacet- (2-chloro-6-methyl-anilide) (obtained by reacting 2-chloro-6-methyl-aniline with chloroacetyl chloride in the presence of sodium acetate, melting point 140 to 141) are suspended in 80 parts by weight of ethanol and with 57 parts by weight of N-methyl-N-eyelohexyl-amine. The temperature rises slightly and a large part of the reaction mixture goes into solution. The mixture is then stirred for 4 hours at room temperature and then for a few hours at 65 to 75 hours. A sample with water and then mixed with dilute hydrochloric acid,
again results in a solution of the precipitate. The alcohol and the excess N-methyl-N-cyclohexyl-amine are then blown off with steam and, after cooling, the remaining 61 is taken up in ether becomes. 42 parts by weight of pure N-methyl-N-eyelohexyl-amino-acet- (2-chloro-6-methyl-anilide) are obtained. The reaction with cyclohexylamine can also take place in benzene.
PATE RUCH:
Process for the production of a new base-substituted fatty acid (2-hw methyl-anilide), characterized in that a compound of the formula
** WARNING ** End of DESC field could overlap beginning of CLMS **.
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH311613T | 1952-02-25 | ||
CH307799T | 1952-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH311613A true CH311613A (en) | 1955-11-30 |
Family
ID=25735346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH311613D CH311613A (en) | 1952-02-25 | 1952-02-25 | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). |
Country Status (1)
Country | Link |
---|---|
CH (1) | CH311613A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10842798B1 (en) | 2019-11-06 | 2020-11-24 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10927096B2 (en) | 2019-03-11 | 2021-02-23 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
US10934263B2 (en) | 2019-03-11 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10968179B2 (en) | 2019-03-11 | 2021-04-06 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11332446B2 (en) | 2020-03-11 | 2022-05-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
-
1952
- 1952-02-25 CH CH311613D patent/CH311613A/en unknown
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11512058B2 (en) | 2019-03-11 | 2022-11-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10828287B2 (en) | 2019-03-11 | 2020-11-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10927096B2 (en) | 2019-03-11 | 2021-02-23 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
US10934263B2 (en) | 2019-03-11 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11643404B2 (en) | 2019-03-11 | 2023-05-09 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
US10968179B2 (en) | 2019-03-11 | 2021-04-06 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11603355B2 (en) | 2019-03-11 | 2023-03-14 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11377422B2 (en) | 2019-03-11 | 2022-07-05 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10842798B1 (en) | 2019-11-06 | 2020-11-24 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11696912B2 (en) | 2019-11-06 | 2023-07-11 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11332446B2 (en) | 2020-03-11 | 2022-05-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH311613A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311606A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311609A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311610A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311608A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311612A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311614A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311607A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311615A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311611A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311629A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311604A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311630A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311632A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311644A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311605A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311603A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311619A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311621A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311631A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH312572A (en) | Process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl) anilide | |
CH311642A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311620A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311639A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311616A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). |